Disappointing FY17 results, although widely anticipated, but most of all a disappoining FY18e guidance with new measures required to adapt to a fast-moving environment. Our model is under review with valuation metrics and target price to be cut.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Disappointing FY17 results, although widely anticipated, but most of all a disappoining FY18e guidance with new measures required to adapt to a fast-moving environment. Our model is under review with valuation metrics and target price to be cut.
